Trial Profile
A Clinical Trial Comparing Adjuvant Clodronate Therapy vs Placebo in Early-Stage Breast Cancer Patients Receiving Systemic Chemotherapy and/or Hormonal Therapy or No Therapy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Apr 2023
Price :
$35
*
At a glance
- Drugs Clodronic acid (Primary) ; Antineoplastics; Hormones; Tamoxifen
- Indications Early breast cancer
- Focus Therapeutic Use
- 31 May 2020 Results assessing MAF biomarker for response prediction by using data from two studies including this study presented at the 56th Annual Meeting of the American Society of Clinical Oncology
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Oct 2009 New source identified and integrated (Oregon Health and Science University Cancer Institute).